Use of Cytomegalovirus Immunoglobulin with Antiviral Therapy for Cytomegalovirus Infection in Transplant Recipients: A Tertiary Care Single-Center Experience

Background Cytomegalovirus (CMV) infection is a major contributor to morbidity and mortality in recipients of hematopoietic stem cell transplant (HSCT), solid organ transplant (SOT), and chimeric antigen receptor T-cell (CAR-T) therapy. While antiviral agents remain the cornerstone of treatment, CMV...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Reem M. Alameer, Bayan Alamro, Khulud Alanazi, Ali Alahmari, Ghadeer Almousa, Abdullah Almohaizeie, Hadeel Samarkandi, Reem S. Almaghrabi
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2026-05-01
Saila:	Viruses
Gaiak:	Cytomegalovirus solid organ transplant hematopoietic stem cell transplant and chimeric antigen receptor T-cell (CAR-T) therapy CMV immunoglobulin
Sarrera elektronikoa:	https://www.mdpi.com/1999-4915/18/6/599
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!